Partner Highlight: Institute of Biological Medicine
Master Compounded Bioidentical Hormone Replacement Therapy
Company Overview:
The Institute of BioIdentical Medicine (IOBIM) is a premier online education platform dedicated to training healthcare providers in compounded bioidentical hormone replacement therapy (cBHRT). For over 15 years, IOBIM has empowered physicians, nurse practitioners, and other medical professionals with the knowledge and skills needed to effectively manage patients receiving BHRT. The institute combines rigorous clinical education with modern technology tools to help practitioners build successful, patient-centered hormone therapy practices.
Mission Statement:
To radically improve hormone therapy practices and the lives of practitioners by providing comprehensive, accessible online education that empowers healthcare providers with the knowledge and skills to effectively manage patients receiving bioidentical hormone replacement therapy.
Unique Value Proposition:
IOBIM offers provider training developed by Dr. Daved Rosensweet, a pioneer recognized as “One of the Biggest Names in Anti-Aging Medicine” by A4M. The institute’s Target Method provides systematic protocols for accurate hormone dosing, with training programs covering both menopause and andropause. Unlike generic hormone courses, IOBIM integrates clinical education with practical tools like BriteScript smart prescribing software and access to patented organic transdermal delivery technology, creating a complete ecosystem for BHRT practice success.
Why We Partner:
The Menopause Association partners with IOBIM because quality provider education is the foundation of exceptional patient care. Many healthcare providers lack adequate training in bioidentical hormone therapy, leaving women without access to effective menopause treatment. IOBIM’s comprehensive curriculum, developed by one of the field’s most experienced practitioners, addresses this gap by training providers in evidence-based protocols that prioritize patient safety and outcomes. The institute’s focus on compounded bioidentical hormones aligns with our mission to connect women with providers who offer personalized, integrative approaches to menopause care. By endorsing IOBIM, we help ensure that more providers have the expertise to serve our community effectively.
Here are some of the core product areas from IOBIM that are particularly relevant to our community of providers and patients.
Training Programs
Menopause Mastery
Comprehensive training on treating women in menopause with bioidentical hormones, covering assessment, dosing protocols, monitoring, and adjustment strategies using The Target Method.
Andropause Mastery
Specialized training for treating men experiencing age-related hormone decline, with protocols for testosterone optimization and comprehensive male hormone management.
The Target Method
Dr. Rosensweet’s proprietary systematic approach to hormone dosing that provides clear protocols for achieving optimal hormone levels while maintaining safety parameters.
BriteScript Integration
Smart prescribing SaaS platform that helps providers dose accurately, stay compliant, and scale their practices confidently with decision support technology.
Testimonials
Key Benefits
For Providers
- Evidence-based training from industry pioneer
- Systematic dosing protocols (Target Method)
- Smart prescribing technology integration
- Flexible online learning format
- Ongoing support and community access
For Patients
- Access to well-trained providers
- Consistent, evidence-based treatment
- Personalized hormone protocols
- Safer organic delivery options
- Better outcomes through provider expertise
How to Get Involved
For Providers:
Visit IOBIM.org to explore available courses, including Menopause Mastery and Andropause Mastery programs. Create an account to access the member’s area and begin your BHRT education journey.
For patients:
Ask your healthcare provider if they have received IOBIM training, or search for IOBIM-trained providers through The Menopause Association’s provider directory.
IOBIM was founded by Dr. Daved Rosensweet, who has been training medical professionals in bioidentical hormone therapy for over 15 years. Dr. Rosensweet graduated from the University of Michigan Medical School in 1968 and was involved in training the first nurse practitioners in the United States. He has been called to Washington to speak before the National Academies of Science, Engineering, and Medicine on “The Safety and Efficacy of Bioidentical Hormones.” The institute’s leadership team includes CEO Andrei Terasenco, VP Joshua Rosensweet, and Creative Director Jenifer Rosensweet, bringing together clinical expertise and business acumen to advance BHRT education.
These statements have not been evaluated by the Food and Drug Administration. The training provided is for educational purposes and providers should always exercise clinical judgment in patient care.